Program 2017-11-15T07:22:54+00:00

Scientific Program

Sunday, May 27, 2018
19:00 Welcome Reception
Monday, May 28, 2018
09:00-11:00 Session 1: Opening Session – Reproductive Medicine, IVF and Genetics: Past Present and Future
The really first step
Past, present and future of IVF
Self-Organization and Symmetry Breaking Through Partnership Between Embryonic and Extra-Embryonic Tissues
SARG In 2058 Ce: Anticipating The Next Forty Years Of IVF Innovations
11:00-11:30 Coffee Break
11:30-13:00 Session 2A: Fertility Preservation 11:30-13:00 Session 2B: Preimplantation Genetic Diagnosis (PGD)
Chair: Alan Handyside, UK
Administration of AMH to prevent loss of ovarian reserve and protect fertility in chemotherapy treatment Basic genetics principles for the non-genetics
Pregnancy following lyophilized sperm in large mammals From Expanded Carrier screening to PGD
Fully Atomized Vitrification System PGD from theory to practice
Cancer genes and fertility treatment: where oncofertility and PGD intersect
13:00-14:00 Lunch Break
14:00-16:00 Session 3A: Recombinant vs. Biosimilar Gonadotropin 14:00-16:00 Session 3B: Preimplantation Genetic Screening (PGS)
Recombinant vs. biosimilar gonadotropin
Recombinant
Biosimilar
Should PGS be implemented to routine IVF practice?
Breast cancer: Non gonadal effects of Gonadotropins Non-inherited chromosomal and genomic abnormalities in human embryos and how to prevent them
Session 3A: Creation of an Artificial Ovary TBA
Creation of artificial ovary: practical issues What causes genomic instability in preimplantation embryos
Printing a 3-D Ovary
16:00-16:30 Coffee Break
16:30-18:00 Session 4A: Stem cells; the CEO of our body 16:30-18:00 Session 4B: Optimizing Egg Yield for IVF
Making human oocytes from stem cells Errors in IVF- Lessons from Aviation
Can we stop ovarian aging? Optimizing results in poor responder patients
TBA The novel POSEIDON stratification of low prognosis patients in ART
Improving IVF: Is there a limit to our ability to manipulate human biology
Tuesday, May 29, 2018
09:00-11:00 Session 5A: FOGSI and ISAR Session 09:00-11:00 Session 5B: Recent Development in Genomic Science and their Applications to ART: Gene Editing (CRISPR)
TBA TBA
TBA TBA
11:00-11:30 Coffee Break
11:30-13:00 Session 6A: Endometrial Receptivity and Implantation 11:30-13:00 Session 6B: Male Infertility
The diagnosis of endometrial receptivity Male infertility
Fresh embryo vs. cryopreserved Novel integrated Genetic screening in men with idopatic azoopermia or sever aligo-azospermia
Session 6A: Searching for the Optimal Vehicle and Dose of Progesterone to Support the Luteal Phase in ART
Searching for the optimal vehicle and dose of progesterone to support the luteal phase in ART Where are we and where should and will we go in evaluating male reproductive potential: The now and future of treating the azoospermic male
Mini hCG for luteal phase support: a more physiologic LPS for ART
13:00-14:00 Lunch Break
14:00-15:30 Session 7A: Reproductive Surgery 14:00-15:30 Session 7B: PCOS: New Insights on Pathophysiology and Diagnostic Criteria
Advanced laparoscopy for endometriosis associated infertility Where does PCOS come from?
The next 40 years….the ART of the possible
Optimizing uterine fibroid management in the infertile patient Debate: Global Freezing:
Hysteroscopy and infertility: state of the art
Laparoscopic and hysteroscopic cesarean niche resection
The impact of laparoscopic surgical management of deep endometriosis on fertility outcome
15:30-16:00 Coffee Break
16:00-17:30 Session 8: Embryo Selection: Invasive vs. None-Invasive Technique
Maximizing successful implantation: TLI, PGS and AnxaV M2 haptlotype
Third party reproductive medicine